tw0122
2週前
.99 getting some cash back from Canada.. Carlsbad, CA, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced the receipt of CAD$1.39 million Canadian SR&ED credits for reimbursement of prior pre-clinical costs for PALI-2108 incurred under the company’s joint development plan with Giiant.
Helter Skelter
3月前
This may blow up to 6 or 7 bucks 😺 (currently 2.75, +96% on 9.2M volume already, 7x OS)
As of November 7, 2024, there were 1,329,516 shares of common stock, $0.01 par value, outstanding.
Stockholders' Equity $6,608,000 / 1,329,516 OS = $4.97 (5 bucks) per share stocholders' equity value.
$PALI